Pancreatic cancer has a grim prognosis. It is usually detected after the disease has spread, and chemotherapy tends to do little to slow the cancer’s growth. Even with treatment, most patients live only about six months after they are diagnosed with the disease.
Researchers in Professor David Tuveson’s laboratory at Cold Spring Harbor Laboratory (CSHL) think it’s possible to do better with a different type of treatment. Part of the problem, they say, is that cancer cells in the pancreas are protected by the dense matrix that surrounds them. The matrix is a mixture of extracellular components and noncancerous cells known as the stroma. All solid tumors contain stroma. In pancreatic cancers, this fibrous material is particularly abundant, making up nearly 90 percent of a tumor’s mass. This stroma impedes anticancer drugs’ from getting to their targets. Additionally, stromal cells secrete factors that actually help the tumors grow.
Overcoming the stroma’s protective influence has been challenging, but new leads from Tuveson’s team, as reported on October 26, 2018 in the journal Cancer Discovery, point to a promising strategy. In fact, the new findings suggest that drugs which target the right cellular pathways can do more than just thwart tumor-supporting cells in the stroma. They may recruit them into the anticancer fight.
A key element of the stroma is a type of cell called a fibroblast. Fibroblasts manufacture the stroma’s connective tissue. They also generate factors that promote cancer cell growth and prevent the immune system from attacking the cancerous cells. Last year Tuveson’s team discovered that the stroma of pancreatic tumors contains at least two types of fibroblasts. One type show features known to support tumor growth, the other type appear to have the opposite effect.
The good news is that the fibroblasts’ identities are not fixed. With the right cues, tumor-promoting fibroblasts can become tumor-restrictors.
“These cells can convert into one another, depending on the cues they get from the microenvironment and from the cancer cells,” explains Giulia Biffi, a postdoctoral researcher in Tuveson’s lab who led the new study. “This is potentially useful because, in theory, you can shift the tumor-promoting cells to tumor-restraining, rather than just depleting the tumor-promoting cells.”
In this new report, Biffi and her colleagues have identified specific molecular signals released by cancer cells that determine fibroblasts’ character within pancreatic tumors. They have discovered that one such molecule, IL-1, drives fibroblasts to take on a tumor-promoting identity. They have also shown how another molecule, TGF-beta, overrides that signal and keeps fibroblasts in a potentially anticancer state even when IL-1 is present.
The researchers are now exploring what happens to pancreatic tumors when they manipulate IL-1 and TGF-beta signaling and convert tumor-promoting fibroblasts to a more beneficial state. They will also investigate what happens when they target these pathways in combination with chemotherapy or cancer immunotherapies. Ultimately, Biffi says, patients may benefit most from a combination of therapies that target both the cancer cells and parts of the microenvironment that support their growth.
Learn more: Turning cells against pancreatic cancer
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- Mens choir raises cash for Pancreatic Cancer UK on December 16, 2018 at 9:53 pm
PANCREATIC Cancer UK has been given a £500 Christmas present by the Vale Harmony Barbershop Chorus. The Pershore-based men's acappella chorus raised the money from singing at a Rotary Club caravanners ... […]
- Local athletes team up to fight pancreatic cancer on December 16, 2018 at 7:23 pm
Altoona, Blair County, Pa. - Basketball players in Altoona teamed up with a local nonprofit on Sunday to fight cancer. The 5th Annual I CAN Sideline Pancreatic Cancer purple game took place during Sun... […]
- Startup Spotlight: PanTher’s drug-delivery patch aims to knock down the ‘wall’ of pancreatic cancer on December 14, 2018 at 4:46 pm
Wherever there has been a stage for biotech entrepreneurs this fall, Laura Indolfi has appeared. And wherever she is, major pharmaceutical companies have been, too. Authoritative biopharma coverage an... […]
- Ask the doctors: Pancreatic cancer’s location makes it difficult to diagnose on December 13, 2018 at 10:02 am
Dear Doctor: Is there a cure for pancreatic cancer? Does anyone know what causes it? Does eating raw steak cause it? Or smoking? Dear Reader: At this time, there is no known cure for pancreatic cancer ... […]
- Pancreatic cancer hard to diagnose on December 12, 2018 at 1:19 am
Q: Is there a cure for pancreatic cancer? Does anyone know what causes it? Does eating raw steak cause it? Or smoking? A: At this time, there is no known cure for pancreatic cancer, the third most dea... […]
- Breast cancer drug could create chink in the armour of pancreatic cancer on December 11, 2018 at 6:43 am
The well-known drug tamoxifen could exploit a weakness in the physical 'scaffolds' around tumours, according to research led by Imperial. The report's authors, led by Imperial College London, say ... […]
- PharmaCyte Discusses Pancreatic Cancer Clinical Trial with Medpace’s Medical Monitor Dr. Lyon Gleich on December 11, 2018 at 5:20 am
PharmaCyte Biotech, Inc. (otcqb:PMCB), a biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box [ ... […]
- Europe Pancreatic Cancer Market and Competitive Landscape - 2018 - ResearchAndMarkets.com on December 11, 2018 at 3:45 am
The "Europe Pancreatic Cancer Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. Europe Pancreatic Cancer Market and Competitive Landscape - 2018, pro... […]
- New Country Mercedes-Benz Helps Rock Away Pancreatic Cancer in CT on December 9, 2018 at 11:08 am
This post was contributed by a community member. During National Pancreatic Cancer Awareness Month in November, New Country Mercedes-Benz hosted the 2nd annual Rock Away Pancreatic Cancer event to ... […]
via Bing News